Analysis of Low-Abundance Host Cell Residual Protein Detection in Monoclonal Antibody Drugs by Liquid Chromatography-Tandem Mass Spectrometry

09

2026.06

European Pharmacopoeia 2026 New Regulation: Simultaneous Testing of Cells and Supernatant Mandatory for Mycoplasma Detection, NAT Method Officially Upgraded as One of the Three Core Methods

05

2026.06

Practical Solutions to Three Major Pain Points in Host Cell Protein ELISA Detection Specificity Bias, Dilution Non-Linearity and Abnormal Recovery

03

2026.06

Key Points for Application and Method Validation Procedures of the Monocyte Activation Test (MAT) Under the Guidance of EP 11.8

27

2026.05

DetecInnova Platform: 3-Hour Rapid Testing at UPB Stage Fortifies Biologics Safety Barriers

27

2026.05

Selection and Preparation of Virus Standard Panels for the Validation of NGS Adventitious Virus Detection

25

2026.05

Considerations on Methodological Validation of Mycoplasma Detection from Traditional Methods to NAT

22

2026.05